Table 1. Number and distribution of individuals analyzed for post-diagnostic survival and post-diagnostic recurrence and levels of the cohort factors considered.

		Survival				Recurrence
		Training Set		Validation Set		Training Set		Validation Set
		Number	Percent	Number	Percent	Number	Percent	Number	Percent
Total		272		146		157		92
N 1 Censored		107	39%	75	51%	31	20%	38	41%
Treatment 2	Chemo 3	253	93%	101	69%	150	96%	67	72%
	Chemo_Other 4	14	5%	25	17%	5	3%	18	20%
	Other 5	5	2%	20	14%	2	1%	7	8%
Preadjuvant Therapy 6	Yes	21	8%	36	25%	7	4%	25	27%
	No	251	92%	110	75%	150	96%	67	73%
Additional Treatment 7	Chemo 3	113	41%	49	34%	106	67%	45	49%
	Chemo_Other 4	37	14%	35	24%	34	22%	35	38%
	Other 5	122	45%	62	42%	17	11%	12	13%
Tumor Stage 8	I_II 9	12	4%	17	12%	5	3%	9	10%
	III 10	239	88%	89	61%	143	91%	59	64%
	IV 11	21	8%	40	27%	9	6%	24	26%
Tumor Grade 12	I or II 13	12	4%	45	31%	6	4%	35	38%
	Rest 14	260	96%	101	69%	151	96%	57	62%
Tumor Residual Disease 15	0 16	71	26%	52	36%	34	22%	30	33%
	1_20 17	167	61%	60	41%	102	65%	40	43%
	>20 18	34	13%	34	23%	21	13%	22	24%
Recurrence 19	Yes	157	58%	92	63%	157	100%	92	100%
	No	115	42%	54	37%	0	0%	0	0%

¹N: Number of patients;

²Treatment: Type of treatment received;

³Chemo: Only chemotherapy;

⁴Chemo_Other: Chemotherapy plus another treatment;

⁵Other: Any treatment other than chemotherapy;

⁶Preadjuvant Therapy: Any treatment that the patient received prior to surgery and sample collection;

⁷Additional Treatment: Treatment given after initial first round treatment;

⁸Tumor Stage: pathological stage of the tumor in AJCC format (Primary Tumor: T; Stage I: IA; IB; IC; Stage II: IIA; IIB; IIC; Stage III: IIIA; IIIB; IIIC; Stage IV: IV);

⁹I_II: Stage I or II ovarian cancer;

¹⁰III: Stage III ovarian cancer;

¹¹IV: Stage IV ovarian cancer;

¹²Tumor Grade: Numeric value used to express the degree of abnormality of cancer cells;

¹³I or II: Grade I or II tumor;

¹⁴Rest: Any tumor grades other than I or II;

¹⁵Tumor Residual Disease: Measure of the largest remaining nodule;

¹⁶0: No macroscopic disease;

¹⁷1_20∶1–20 mm;

¹⁸>20: Greater than 20 mm;

¹⁹Recurrence: Return of cancer.